It traces a research trajectory from phenotypic markers (e.g., “Overweight,” “Body-Mass Index,” “Gestational Diabetes Mellitus,” “Preeclampsia,” “Hypertension”) to molecular mechanisms, emphasizing inflammation (“Inflammation,” “Oxidative Stress,” “Activation”) and metabolic regulation (“Metabolism,” “Insulin-Resistance,” “Glucose”). Here, INS is linked to hypertensive disorder.